Before taking this medicine

LIBTAYO may cause severe immune-mediated reactions, infusion-related reactions, and embryo-fetal toxicity, requiring close monitoring and possible discontinuation in certain cases.

Precautions for LIBTAYO Use

LIBTAYO has the potential to cause severe immune-mediated adverse reactions, which can affect multiple organ systems, including the lungs (pneumonitis), colon (colitis), liver (hepatitis), and endocrine glands. These reactions require close monitoring and may necessitate withholding or permanently discontinuing treatment, as well as administration of corticosteroids for management. Infusion-related reactions are also common and should be addressed by adjusting the infusion rate or discontinuing the drug. Additionally, LIBTAYO can cause fetal harm and should not be used during pregnancy, with effective contraception recommended for women of reproductive potential. Further precautions related to specific populations are not specified in the description.